<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Aachen_PolicyPractices"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Aachen/PolicyPractices">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Aachen/PolicyPractices&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Aachen/PolicyPractices&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Aachen/PolicyPractices&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Aachen/PolicyPractices" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Aachen/PolicyPractices</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2014.igem.org</H3><DIV class="navDiv" style="top:14px; position:fixed; z-index: 1; border-bottom-style: solid; border-bottom-width: 3px; border-bottom-color: #bf1521;"><NAV style="width: 1250px;"><UL align="left" style=""><LI style="width:129px"><A href="https://2014.igem.org/Team:Aachen/Project">Project</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Project/2D_Biosensor">2D Biosensor</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Project/FRET_Reporter">The REACh Construct</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Project/Model">Modeling</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Project/Measurement_Device"><I>WatsOn</I></A></LI><LI style="border-bottom:2px solid; border-bottom-color: white;"><A href="https://2014.igem.org/Team:Aachen/Project/Gal3">Galectin-3</A></LI><LI style="border-bottom:2px solid; border-bottom-color: white;"><A href="https://2014.igem.org/Team:Aachen/OD/F device">OD/F Device</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Parts">Parts</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Achievements">Achievements</A></LI></UL><LI style="width:216px"><A href="https://2014.igem.org/Team:Aachen/Interlab_Study">Interlab Study</A></LI><LI style="width:250px"><A href="https://2014.igem.org/Team:Aachen/PolicyPractices">Policy &amp; Practices</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Collaborations/Kaiser-Karls-Gymnasium">Kaiser-Karls-Gymnasium</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Collaborations/Neanderlab">NEAnderLab</A></LI><LI style="border-bottom:2px solid; border-bottom-color: white;"><A href="https://2014.igem.org/Team:Aachen/Collaborations/MakerFaire">MakerFaire</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Safety">Safety</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/PolicyPractices/Economics">Economical View</A></LI><LI style="border-bottom:2px solid; border-bottom-color: white;"><A href="https://2014.igem.org/Team:Aachen/PolicyPractices/BioBrickIntellectualProperty">BBa Intellectual Property</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Blog">Blog</A></LI><LI style="width:215px"><A href="https://2014.igem.org/Team:Aachen/Collaborations">Collaborations</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Meetup">Aachen Meetup</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Collaborations/Bielefeld">Bielefeld</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Collaborations/Methane_Sensor">Braunschweig</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Collaborations/Freiburg">Freiburg</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Collaborations/Heidelberg">Heidelberg</A></LI><LI style="width:157px"><A href="https://2014.igem.org/Team:Aachen/Notebook">Notebook</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Notebook/Wetlab">Wetlab</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Notebook/Protocols">Protocols</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Notebook/Engineering">Engineering</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Notebook/Software">Software</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Notebook/LabEquipment">Equipment</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Notebook/Index">Abbreviations</A></LI><LI style="width:109px"><A href="https://2014.igem.org/Team:Aachen/Attributions">Team</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Attributions#members">Members</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Attributions#instructors">Instructors</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Attributions#partners">Partners</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Attributions#support">Attributions</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/SecretHappenings"><I>Mr Holmes</I></A></LI></NAV></DIV><DIV id="contentdiv" style="margin-left: auto; margin-right: auto; width: 100%; position: absolute; bottom: 15px; top: 60px;"><TABLE class="transbg" width="100%" cellspacing="0"><TBODY><TR><TD class="contentcell" width="95%" align="justify"><H1><SPAN class="mw-headline" id="Policy_.26_Practices"> Policy &amp; Practices </SPAN></H1><P>During the past summer, we not only refined the technical and biological sides of <I>Cellock Holmes</I> but also considered other aspects of our iGEM project such as <B>social acceptance</B>, <B>biosafety</B> and <B>economical relevance</B>.  Will society accept the technology we develop? How can we convince skeptics that synthetic biology is safe? Does our product have economical relevance and how can we best market what we built? What is the target group that might benefit from our devices, and can we make our developments available to not only the privileged population but to everybody in the world? At the meetup of the German iGEM teams in Munich earlier this summer, we also prepared a suggestion on how to handle <B>intellectual proporty rights on BioBricks</B>.
</P><P>These are only a few of the questions we discussed within our team. To read more about the different aspects of our Policy &amp; Practices work, please click on a panel below:  
</P><CENTER><P><UL class="team-grid" style="width:1040px"><LI style="width:186px;margin-left: 11px;margin-right: 11px;margin-bottom: 11px;margin-top: 11px;"><A class="menulink" href="https://2014.igem.org/Team:Aachen/PolicyPractices#ppsocialacceptance" style="color:black"><DIV class="menusmall-item menusmall-info" style="height: 180px; width: 180px;"><DIV class="menukachel" style="top: 32%;line-height: 1.5em;">Social Acceptance</DIV></DIV></A></LI><LI style="width:186px;margin-left: 11px;margin-right: 11px;margin-bottom: 11px;margin-top: 11px;"><A class="menulink" href="https://2014.igem.org/Team:Aachen/PolicyPractices#ppbiosafety" style="color:black"><DIV class="menusmall-item menusmall-info" style="height: 180px; width: 180px;"><DIV class="menukachel" style="top: 40%;line-height: 1.5em;">Biosafety</DIV></DIV></A></LI><LI style="width:186px;margin-left: 11px;margin-right: 11px;margin-bottom: 11px;margin-top: 11px;"><A class="menulink" href="https://2014.igem.org/Team:Aachen/PolicyPractices#ppeconomics" style="color:black"><DIV class="menusmall-item menusmall-info" style="height: 180px; width: 180px;"><DIV class="menukachel" style="top: 32%;line-height: 1.5em;">Economical View</DIV></DIV></A></LI><LI style="width:186px;margin-left: 11px;margin-right: 11px;margin-bottom: 11px;margin-top: 11px;"><A class="menulink" href="https://2014.igem.org/Team:Aachen/PolicyPractices#ppbbaip" style="color:black"><DIV class="menusmall-item menusmall-info" style="height: 180px; width: 180px;"><DIV class="menukachel" style="top: 23%;line-height: 1.5em;">Intellectual Property on BioBricks</DIV></DIV></A></LI><LI style="width:186px;margin-left: 11px;margin-right: 11px;margin-bottom: 11px;margin-top: 11px;"><A class="menulink" href="https://2014.igem.org/Team:Aachen/PolicyPractices#ppblog" style="color:black"><DIV class="menusmall-item menusmall-info" style="height: 180px; width: 180px;"><DIV class="menukachel" style="top: 40%;line-height: 1.5em;">Blog</DIV></DIV></A></LI></UL></P></CENTER></TD></TR></TBODY></TABLE><TABLE class="transbg" width="100%" cellspacing="0"><TBODY><TR><TD class="contentcell" width="95%" align="center"><H2><SPAN class="mw-headline" id="Spreading_the_Idea_of_Synthetic_Biology"> Spreading the Idea of Synthetic Biology </SPAN></H2><P>How can we convince people that the technology we develop is safe to use and that the problems we tackle with our project concern everybody? Unfortunately, lots of people around the world are scared of genetically modified organisms and any application related to them. Though we believe that <B>natural skepticism</B> towards new and unproved technologies is not just good but especially desirable, the current fear some people encounter gene technology with is a bit disproportionate and might be counterproductive to technological and scientific advance in related fields.
</P><P>However, as reported, for example, in an <A href="http://www.rundschau-online.de/magazin/gentechnik--risiko-oder-chance-,15184902,15929266.html" class="external text" rel="nofollow">article</A> published in a major local newspaper's magazine, Kölner Stadtanzeiger, the social acceptance of biotechnological products could be higher if people felt informed better and understood the underlying science. Following up on this, we thought about how we can inform people <B>factually but in a comprehensible way</B> about gene technology and synthetic biology. Before we talk about fancy devices in synthetic biology, how can we <B>get down to the underlying issue</B> of social rejection of gene technology in general? 
</P><P>At the same time, <B>young students</B> interested in science and engineering are the most valuable future source of innovation. One day, they might be the researchers who develop the solutions to the most pressing issues of our world. For that reason, informing this group of people is of utmost importance and was therefore prioritized in our Policy &amp; Practices work.
</P><P>Combining these two thoughts, we visited <B>two schools</B>, the <A href="https://2014.igem.org/Team:Aachen/Collaborations/Kaiser-Karls-Gymnasium" class="external text" rel="nofollow">Kaiser-Karls-Gymnasium</A> in Aachen and the <A href="https://2014.igem.org/Team:Aachen/Collaborations/Neanderlab" class="external text" rel="nofollow">NEAnderLab</A> in Hilden, where we talked to students about synthetic biology and the iGEM competition, but also explained the scientific background and social aspects of our project. A delegation of our team also visited the <A href="https://2014.igem.org/Team:Aachen/Collaborations/MakerFaire" class="external text" rel="nofollow">MakerFaire</A> in Hannover, a family-friendly <B>exhibition for tinkerers</B> of all kinds, to spread the idea of synthetic biology and to discuss our project with the public. When we organized the <A href="https://2014.igem.org/Team:Aachen/Meetup" class="external text" rel="nofollow">Aachen iGEM Meetup 2014</A>, we also made sure to include a <B>public part</B> where all teams who participated in our meetup had the opportunity to present their project to a general audience.
</P><P>In general, we received <B>positive feeback throughout</B>. The students we worked with in the NEAnderLab also filled out evaluation sheets, giving us <A href="https://2014.igem.org/Team:Aachen/Collaborations/Neanderlab#neanderlabevaluation" class="external text" rel="nofollow">very good marks</A> for our collaboration. Through our work with the different people we encountered during our Policy &amp; Practices work, we were able to inform people in a comprehensible way about synthetic biology and gene technology in general. We see this as a <B> successful first step towards a society that embraces the possibilities provided by Synthetic Biology</B>, and recommend approaches like the school collaborations to other iGEM teams who want the spread the idea of synthetic biology.
</P><P>To read more about our different public projects, please click on the respective logo below.
</P><P><UL class="team-grid" style="width:1064px;"><LI style="width:220px;margin-left: 23px;margin-right: 23px;margin-bottom: 23px;margin-top: 23px;"><A href="https://2014.igem.org/Team:Aachen/Collaborations/Kaiser-Karls-Gymnasium" style="color:black"><DIV class="team-item team-info" style="width:214px;height:214px;"><B> Kaiser-Karls-Gymnasium</B>
      Teaching Module &quot;Synthetic Biology&quot; for High Schools
      </DIV></A></LI><LI style="width:220px;margin-left: 23px;margin-right: 23px;margin-bottom: 23px;margin-top: 23px;"><A href="https://2014.igem.org/Team:Aachen/Collaborations/Neanderlab" style="color:black"><DIV class="team-item team-info" style="width:214px;height:214px;"><B> NEAnderLab </B>
      In Cooperation with the Gymnasium an Neandertal
      </DIV></A></LI><LI style="width:220px;margin-left: 23px;margin-right: 23px;margin-bottom: 23px;margin-top: 23px;"><A href="https://2014.igem.org/Team:Aachen/Collaborations/MakerFaire" style="color:black"><DIV class="team-item team-info" style="width:214px;height:214px;"><B> MakerFaire </B>
      Visit of a DIY Exhibition
      </DIV></A></LI><LI style="width:220px;margin-left: 23px;margin-right: 23px;margin-bottom: 23px;margin-top: 23px;"><A href="https://2014.igem.org/Team:Aachen/Meetup" style="color:black"><DIV class="team-item team-info" style="width:214px;height:214px;"><B>  Aachen iGEM Meetup 2014 </B>
      Including Public Presentations
      </DIV></A></LI></UL></P></TD></TR></TBODY></TABLE><TABLE class="transbg" width="100%" cellspacing="0"><TBODY><TR><TD class="contentcell" width="95%" align="center"><H2><SPAN class="mw-headline" id="Biosafety"> Biosafety </SPAN></H2><P>Our iGEM team is committed to reflect all aspects of the entire project, including biosafety. From the beginning on, the team thoroughly discussed safety issues that could potentially arise with the implementation of <I>Cellock Holmes</I>. The results of these discussions fundamentally influenced the design of <A href="https://2014.igem.org/Team:Aachen/Project/Measurement_Device" class="external text" rel="nofollow"><I>Watson</I></A> and the choice of potential application fields. Read more about our safety considerations on our <A href="https://2014.igem.org/Team:Aachen/Safety" class="external text" rel="nofollow">Safety</A> page.
</P></TD></TR></TBODY></TABLE><TABLE class="transbg" width="100%" cellspacing="0"><TBODY><TR><TD class="contentcell" width="95%" align="center"><H2><SPAN class="mw-headline" id="Economical_View"> Economical View </SPAN></H2><P>The economical considerations regarding our project were carried out according to the motto: 
</P><P><B>Make the world a better place - Open access for scientific advance</B></P><P>For both our <A href="https://2014.igem.org/Team:Aachen/Project/Measurement_Device" class="external text" rel="nofollow"><I>WatsOn</I></A> and our <A href="https://2014.igem.org/Team:Aachen/OD/F_device" class="external text" rel="nofollow">OD/F Device</A>, we are following an economical strategy focused on the open source principle. Low cost and the use of easily available parts have <B>heavily influenced the design choices</B> made when developing our devices. You can find more information on our page <A href="https://2014.igem.org/Team:Aachen/PolicyPractices/Economics" class="external text" rel="nofollow">Economical View</A>.
</P></TD></TR></TBODY></TABLE><TABLE class="transbg" width="100%" cellspacing="0"><TBODY><TR><TD class="contentcell" width="95%" align="center"><H2><SPAN class="mw-headline" id="Intellectual_Property_on_BioBricks"> Intellectual Property on BioBricks </SPAN></H2><P>During the meetup of the German iGEM teams from 23rd to 25th May also workshops took place in which amongst others we discussed the topic of bioethics. Moral questions were addressed, regarding the value of life and human influence on it, as well as questions dealing with the possible socioeconomic effects of synthetic biology.
</P><P>Especially the topic of an <B>open source vs. patent</B> controlled field accounted for a large part of the discussion. During the discussion one student brought up the point that the legal status of parts in registry remains unclear, and that there are parts where only upon a closer look it becomes clear that the rights are company–owned. Because the issue of <B>uncertain legal status of parts</B> in the registry persists, the German iGEM teams <B>wrote a proposal</B> on how to deal with intellectual property rights in the Registry of Standard Biological Parts.
</P><P>For for information on intellectual property on BioBricks, read the <A href="https://2014.igem.org/Team:Aachen/PolicyPractices/BioBrickIntellectualProperty" class="external text" rel="nofollow">full proposal</A> the German iGEM teams composed.
</P></TD></TR></TBODY></TABLE><TABLE class="transbg" width="100%" cellspacing="0"><TBODY><TR><TD class="contentcell" width="95%" align="center"><H2><SPAN class="mw-headline" id="Blog"> Blog </SPAN></H2><P>On our <A href="https://2014.igem.org/Team:Aachen/Blog" class="external text" rel="nofollow">Blog</A> we post entries about recent news concerning our team's work and activities. We also write about general news from the field of synthetic biology, biotechnology and medicine. 
</P></TD></TR></TBODY></TABLE></DIV><DIV class="footerDiv" align="center" style="margin-bottom:-10px; background:#0069b3;"><CENTER><A class="footerCenter" href="https://2014.igem.org/Team:Aachen/Contact">Contact</A><A class="footerCenter" href="https://2014.igem.org/Team:Aachen/Disclaimer">Disclaimer</A></CENTER></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2014.igem.org/Team:Aachen/PolicyPractices">http://2014.igem.org/Team:Aachen/PolicyPractices</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Aachen/PolicyPractices" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Aachen/PolicyPractices" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Aachen/PolicyPractices&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Aachen/PolicyPractices&amp;oldid=398064" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2014.igem.org:Privacy_policy" title="2014.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2014.igem.org:General_disclaimer" title="2014.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>